Itau Unibanco Holding S.A. Buys New Holdings in Encompass Health Corp (EHC)

Share on StockTwits

Itau Unibanco Holding S.A. bought a new stake in shares of Encompass Health Corp (AMEX:EHC) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,655 shares of the company’s stock, valued at approximately $383,000.

A number of other hedge funds also recently bought and sold shares of EHC. BlackRock Inc. purchased a new position in Encompass Health during the 1st quarter valued at about $622,184,000. JPMorgan Chase & Co. purchased a new position in Encompass Health during the 1st quarter valued at about $221,881,000. Lord Abbett & CO. LLC purchased a new position in Encompass Health during the 1st quarter valued at about $116,238,000. Victory Capital Management Inc. purchased a new position in Encompass Health during the 1st quarter valued at about $101,978,000. Finally, Northern Trust Corp purchased a new position in Encompass Health during the 1st quarter valued at about $88,764,000. 93.18% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have weighed in on EHC shares. Piper Jaffray Companies raised Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 price target for the company in a research report on Friday, July 27th. Mizuho reiterated a “buy” rating and set a $82.00 price target on shares of Encompass Health in a research report on Thursday, July 26th. Credit Suisse Group lifted their price target on Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. Finally, SunTrust Banks reiterated a “buy” rating and set a $82.00 price target on shares of Encompass Health in a research report on Friday, July 20th. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Encompass Health presently has a consensus rating of “Buy” and an average price target of $71.10.

In related news, insider Andrew L. Price sold 9,457 shares of the business’s stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total value of $756,938.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Cheryl B. Levy sold 28,955 shares of the business’s stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $78.00, for a total value of $2,258,490.00. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Shares of EHC opened at $57.67 on Wednesday. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health Corp has a 12-month low of $40.86 and a 12-month high of $59.29.

Encompass Health (AMEX:EHC) last issued its quarterly earnings results on Wednesday, July 25th. The company reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.83 by $0.16. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.03 billion. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The business’s revenue for the quarter was up 10.5% on a year-over-year basis. analysts expect that Encompass Health Corp will post 2.72 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 15th. Stockholders of record on Monday, October 1st will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date is Friday, September 28th. This is an increase from Encompass Health’s previous quarterly dividend of $0.25.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Recommended Story: Hedge Funds Explained

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply